The FDA approved dihydroergotamine (DHE) mesylate injection (Brekiya) to treat acute migraine (with or without aura) and ...

Copaxone and generic versions of glatiramer acetate are injected under the skin at 20 mg/mL daily or 40 mg/mL three times a ...

Global Prefilled Syringes Market was valued at US$ 1,432.2 million in 2020 and is anticipated to reach US$ 3,301.1 million by 2027 displaying an elevated CAGR of 10% over the forecast period ...

Healthcare Packaging Editor-in-Chief Liz Cuneo talks with founder of SOLUtion Medical, Julia Anthony, about how their prefilled syringe reduces preparation steps. May 2, 2025 Follow this podcast on ...

In early April, the company reported that the FDA had approved a prefilled syringe version of Vyvgart Hytrulo that will allow patients to administer the drug themselves at their homes. Meanwhile ...

Regeneron Pharmaceuticals (REGN) reported its first-quarter 2025 earnings, revealing a miss on both earnings and revenue expectations. The company posted earnings per share (EPS) of $8.22, falling ...

Adding insult to injury, the FDA declined to approve a prefilled syringe of its ophthalmology cornerstone. Regeneron’s shares tumbled 7% pre-market Tuesday morning on a first quarter earnings miss ...

JMI Syringes & Medical Devices reported a 234% growth in its net profit during the first nine months of FY2024-25, driven by increased sales and product price hikes. According to its quarterly report ...

The deal, for which financial details weren’t disclosed, gives PCI its first production site in North America for prefilled syringes and cartridges, PCI said in a recent press release.

The pre-filled syringes industry is growing at an exponential rate. With increasing demand for self-administration, a rise in biologics, large-volume delivery and the delayed EU MDR at the ...

The treatment is designed for patients after prior corticosteroid or immunoglobulin therapy and will be available as a vial or prefilled syringe, administered weekly and later adjusted to every other ...